Emergent Biosolutions (EBS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 191,280 | 164,649 | 179,300 | 342,034 | 315,627 |
| Receivables | 189,489 | 129,134 | 146,100 | 129,357 | 108,630 |
| Inventories | 139,373 | 155,196 | 142,800 | 68,889 | 70,529 |
| TOTAL | $541,308 | $476,649 | $485,400 | $556,034 | $509,741 |
| Non-Current Assets | |||||
| PPE Net | 419,157 | 411,269 | 407,200 | 386,457 | 380,240 |
| Intangibles | 160,903 | 164,815 | 168,700 | 70,203 | 71,757 |
| Other Non-Current Assets | 17,523 | 15,734 | 8,900 | 11,508 | 8,745 |
| TOTAL | $597,583 | $591,818 | $584,800 | $468,168 | $460,742 |
| Total Assets | $1,138,891 | $1,068,467 | $1,070,200 | $1,024,202 | $970,483 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 41,629 | 46,216 | 41,800 | 30,111 | 29,604 |
| Accrued Expenses | 39,811 | 31,353 | 42,700 | 36,544 | 26,200 |
| Other current liabilities | 2,852 | 2,337 | 2,400 | 2,393 | 1,710 |
| TOTAL | $96,813 | $86,870 | $100,100 | $75,432 | $72,926 |
| Non-Current Liabilities | |||||
| Long Term Debt | 13,482 | 13,469 | 13,500 | 248,994 | 248,693 |
| Deferred Revenues | 9,750 | 6,964 | 13,200 | 4,509 | 15,412 |
| Other Non-Current Liabilities | 26,995 | 27,483 | 27,000 | 11,100 | 11,173 |
| TOTAL | $103,732 | $100,317 | $57,800 | $285,060 | $276,958 |
| Total Liabilities | $200,545 | $187,187 | $157,900 | $360,492 | $349,884 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,020 | 49,823 | 49,495 | 41,395 | 41,212 |
| Common Shares | 51 | 50 | 100 | 41 | 41 |
| Retained earnings | 349,783 | 299,639 | 337,100 | 303,132 | 269,581 |
| Other shareholders' equity | -4,057 | -2,893 | -3,200 | -3,318 | -3,022 |
| TOTAL | $938,346 | $881,280 | $912,300 | $663,710 | $620,599 |
| Total Liabilities And Equity | $1,138,891 | $1,068,467 | $1,070,200 | $1,024,202 | $970,483 |